Meghmani Organics Expands Production of Lambda-Cyhalothrin Technical
Meghmani Organics Ltd. (MOL) has increased its existing production of lambda-cyhalothrin technical to 2,400 MT in a newly setup plant in Dahej with complete backward integration. This initiative is in line with Atmanirbhar Bharat, a vision of the Indian government. MOL, with its renewed and state-of-the-art formulation facility at Panoli, Gujarat, already offers global customers lambda-cyhalothrin in various formulations, such as CS, EC, SL, and WP.
MOL also announces commencement of another new multi-functional plant for flubendamide with initial capacity of 300 MTPA, beta-cyfluthrin with capacity of 600 MTPA, and pymetrozine with initial capacity of 600 MTPA. This is in continuation to company’s strategic decision to meet growing agrochemical demand in domestic and global markets. MOL is already in the process to announce more product launches in coming days.
MOL’s bifenthrin production facility was also expanded recently with new capacity of 2,200 MTPA. It is well focused to meet the growing global demand and service to its customers MOL will produce cyfluthrin and spiromesifen with initial capacity of 500 MTPA for each product in its new facility in Dahej.
With its unique production base and growing global footprint, backed by prudent capital investment plans, MOL is ensuring sustainable growth long term and creating value for farmers, customers, and other stakeholders.
Get The Newsletter Today!
